Therefore, in the context of MASLD, an imbalance with increased sympathetic and decreased parasympathetic input to adipose tissue could potentially lead to decreased adiponectin levels, contributing to the progression of the disease [34]. The gene discussed is ADIPOQ; the disease is metabolic dysfunction-associated steatotic liver disease.